Skip to content
The Policy VaultThe Policy Vault

Xarelto — Medical Mutual

Venous Thromboembolism in Acutely Ill Medical Patients, Prophylaxis

Reauthorization criteria

  • Response to therapy is required for continuation unless otherwise noted

Approval duration

60 days